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introduction
Delirium is a common manifestation in the elderly, with 
studies quoting a prevalence of up to 14% in the community in 
those aged 85 years and older.1 It occurs in 10-34% of patients 
living in long term care facilities,2 and occurs in 30% of patients 
presenting to the accident and emergency departments.3 Despite 
the fact that 10-42% suffer from delirium during a hospital 
stay, complicating 17-61% of major surgical procedures, it is 
unfortunately only recognized in 20-50% of cases.1,4 Despite 
the higher prevalence in the elderly population, it may present 
in all age groups, identified as per the ‘American Psychiatric 
Association’ (APA) Diagnostic and Statistical Manual (DSM-IV-
TR and DSM-V Proposed Revision) criteria (Table 1).5
Medications are potential causes for delirium, accounting 
for as much as 39% of cases of delirium in the elderly, with the 
latter population being more at risk than other age groups due 
to altered pharmacokinetic and pharmacodynamics associated 
with the aging process.6
Proton pump inhibitors (PPIs) in particular are known to 
cause neuropsychiatric symptoms. One such PPI is omeprazole, 
a racemic mixture of two active enantiomers, classified as 
an inhibitor of the H+/K+-ATPase found on gastric parietal 
cells.7 Omeprazole-induced delirium has been documented in 
literature. One study on a small subgroup of cancer patients 
documented that histamine receptor 2 antagonists, also used 
as a treatment for gastritis, were more commonly associated 
with delirium than PPIs.8 That said, such cases have all been 
associated with metabolic and electrolyte disturbances, most 
notably hyponatremia and hypomagnesemia.7,9 We would like 
to report a case of omeprazole-induced delirium which clearly 
correlates with the time of its administration and omission. To 
our knowledge, this is the first case to document such a causal 
relationship without any other causes of delirium such a PPI-
induced electrolyte disturbances.
pharmacoVIgIlaNce
omeprazole-INduced delIrIum mark abelanicola aquilinaalex attard
case report
An eighty-five year old gentleman was admitted under 
surgical care because of a possible upper gastrointestinal 
(GI) bleed. He was previously well, with no relevant past 
medical history and fully independent prior to admission. On 
initial assessment at the emergency department, he was alert 
and oriented, haemodynamically stable and neurologically 
intact. In view of his severe epigastric pain, he was started 
on 40mg twice a day of intravenous omeprazole (Losec®), a 
proton-pump inhibitor, as part of the standard management 
protocol, which was later given as tablets. Twelve hours later, 
the patient appeared to be acutely confused, delirious and 
uncooperative. These symptoms got progressively worse during 
his admission.  A collateral history from his relatives did not 
reveal any remarkable evidence of erratic alcohol or other drug 
dependence. Physical examination was unremarkable. 
The patient was inattentive and incoherent, and thinking 
was clearly disorganised, with an altered level of consciousness 
manifesting itself as hyperactivity, reported by various nursing 
personnel. These symptoms were acute in onset and fluctuating. 
The acute fluctuating cognitive disturbance with the impression 
that the cause of the symptoms was organic in origin supported 
the diagnosis of delirium as per the Assessment Method (CAM) 
and APA DSM-IV-TR and DSM-V diagnostic criteria.5,6
Investigation of his epigastric pain did not reveal evidence of 
any acute GI bleeding and a diagnosis of probable gastritis was 
made. However, the persistence of delirium beyond the initial 
few days of admission prompted further investigations (Table 
2)5 in order to identify any possible contributing factor towards 
the delirium, including electrolyte disturbances, metabolic 
disorders, sepsis, hypoxia, constipation, organ failure, and 
hypoxia, amongst others.10
Brain computer tomography (CT) scan and 
Electroencephalogram (EEG) are most often recommended to 
exclude acute (which need immediate management) or chronic 
intracranial pathologies such as a cerebrovascular event or a 
newly diagnosed space-occupying lesion. Despite them being 
used to identify or confirm specific diagnoses, thereby allowing 
a clinician to manage the patient accordingly, one should keep in 
mind that both CT and EEG have very high false negative (17%) 
and false positive (22%) rates.  One should therefore understand 
that further tests such as magnetic resonance imaging (MRI) 
may be needed if there is a diagnostic suspicion, even if results 
are initially normal. That said, one would expect a higher 
diagnostic yield with CT in patients with focal neurological 
deficits.11 The CT scan revealed only an element of brain atrophy, 
which was thought to be consistent with this patients’ age. There 
was no evidence of acute infarction or any brain pathology. 
•	 Altered consciousness with inattention difficulties
•	 Cognitive or perceptual disturbances (unrelated to 
dementia)
•	 Acute onset of symptoms (hours to days), typically 
fluctuating in nature
•	 History, clinical assessment and investigations 
suggestive of organic causes for symptoms  (including 
medication)
Table 1: Diagnostic and statistical manual criteria (DSM-
IV-TR and DSM-V).5
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The background EEG showed a generalised slowing of the 
background rhythm with no focal or epileptiform features, 
consistent with a non-specific encephalopathy (Figure 1).
This patient was not started on any medication, other than 
omeprazole during his hospital stay, and therefore the possibility 
of a drug-induced delirium was not considered immediately. 
However, as a last attempt, the omeprazole was stopped and 
he was given ranitidine instead for his GI symptoms. Twelve 
hours later, the patient was back to his pre-morbid state, fully 
oriented, talkative, independent and co-operative with doctors 
and paramedical staff. After an 8 day hospital stay, he was 
discharged. 
conclusion
Despite the fact that 48% of patients report adverse effects 
secondary to omeprazole ingestion, only a very small minority 
complain of neurological symptoms, the majority of which 
being headaches (3% of total side-effects).8 Neuropsychiatric 
symptoms including delirium have been reported in the 
literature9 and are also documented in the product literature. 
The summary of product characteristics (for Losec®)12 
acknowledges that psychiatric symptoms including delirium can 
occur rarely, secondary to severe hypomagnesaemia in patients 
treated with proton pump inhibitors for at least 3 months. 
Case reports also report delirium secondary to hyponatremia 
Figure 1: EEG showing 
non-specific slowing of 
the background rhythm 
and CT scan of the brain 
showing generalised 
atrophy.
Blood Tests
•	 Complete blood count
•	 Electrolytes (sodium, potassium, chloride, calcium, 
magnesium, phosphate, iron profile)
•	 Liver function tests including bilirubin, albumin, liver 
enzymes, ammonia
•	 Endocrine investigations including thyroid function 
tests, folate, vitamin B12
•	 Blood glucose
•	 Blood cultures
•	 Arterial Blood Gases (for Hypoxia and Hypercapnia)
•	 Toxicology
•	 Inflammatory markers including Estimated 
Sedimentaiton Rate (ESR), C-reactive protein (CRP), 
ferritin
Urine Tests
•	 Urinalysis
•	 Urine Cultures
Neuroimaging
•	 CT Brain
•	 Electroencephalography
Others
•	 CSF Analysis (Biochemistry and Cytology)
•	 ECG
•	 Pulse Oximetry
•	 Chest X-Ray
•	 Abdominal X-Ray
Table 2: Basic investigations for diagnosing cause for 
delirium.5
in patients treated with proton pump inhibitors for at least 3 
months.13 Notwithstanding this fact, the authors conducted 
a thorough literature search and did not find any case of 
documented omeprazole-induced delirium whereby sodium and 
magnesium levels are normal. In conclusion, physicians should 
not undervalue the possibility of documented omeprazole-
induced non-organic psychosis. Earlier recognition and prompt 
cessation of the drug will avoid unnecessary investigations as 
well as reduce the length of hospital stay.  re
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